Filter Results:
(5,434)
Show Results For
- All HBS Web
(5,434)
- People (18)
- News (2,019)
- Research (2,722)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,993)
Show Results For
- All HBS Web
(5,434)
- People (18)
- News (2,019)
- Research (2,722)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,993)
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
ignored health care altogether, leaving it to government or dutifully paying their mandated health contributions. Many U.S. employers are dropping View Details
- Article
Behavioral Hazard in Health Insurance
By: Katherine Baicker, Sendhil Mullainathan and Joshua Schwartzstein
A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is ample... View Details
Baicker, Katherine, Sendhil Mullainathan, and Joshua Schwartzstein. "Behavioral Hazard in Health Insurance." Quarterly Journal of Economics 130, no. 4 (November 2015): 1623–1667. (Online Appendix.)
- September 1993 (Revised July 1995)
- Background Note
Public Policy and the Manager: Conceptual Framework
Government intervention in markets may have significant effects--both positive and negative--on a firm's strategic options and its performance outcomes. Thus the ability to analyze the origins, implications, and dynamics of public policy is a critical managerial skill... View Details
Keywords: Policy; Management Skills; Government and Politics; Adoption; Business Strategy; Performance Evaluation; Economic Systems
Emmons, Willis M., III. "Public Policy and the Manager: Conceptual Framework." Harvard Business School Background Note 794-028, September 1993. (Revised July 1995.)
"Behavioral Hazard in Health Insurance"
A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is... View Details
- 2009
- Working Paper
Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings
By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter
The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions. We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details
Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery
Rhatigan, Joseph, Sachin H Jain, Joia S. Mukherjee, and Michael E. Porter. "Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings." Harvard Business School Working Paper, No. 09-093, February 2009.
- 24 May 2022
- News
Health Equity: Aging in America
- 11 Dec 2018
- News
Herzlinger Editorial Influences Federal Healthcare Policy
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- Article
Shifting toward Defined Contributions—Predicting the Effects
By: Kevin Schulman, Barak D. Richman and Regina E. Herzlinger
Schulman, Kevin, Barak D. Richman, and Regina E. Herzlinger. "Shifting toward Defined Contributions—Predicting the Effects." New England Journal of Medicine 370, no. 26 (June 26, 2014).
- July 2021
- Article
Making Medications Stick: Improving Medication Adherence by Highlighting the Personal Health Costs of Non-compliance
By: Jon M. Jachimowicz, Joe J. Gladstone, Dan Berry, Charlotte L. Kirkdale, Tracey Thornley and Adam D. Galinsky
Poor compliance of prescription medication is an ongoing public health crisis. Nearly half of patients do not take their medication as prescribed, harming their own health while also increasing public health care costs. Despite these detrimental consequences, prior... View Details
Keywords: Prescription Drugs; Medication Adherence; Personal Health Costs; Health; Behavior; Motivation and Incentives; Communication Strategy
Jachimowicz, Jon M., Joe J. Gladstone, Dan Berry, Charlotte L. Kirkdale, Tracey Thornley, and Adam D. Galinsky. "Making Medications Stick: Improving Medication Adherence by Highlighting the Personal Health Costs of Non-compliance." Behavioural Public Policy 5, no. 3 (July 2021): 396–416.
- March 2021 (Revised July 2021)
- Case
Aledade
By: Regina E. Herzlinger, Samyukta Mullangi and Nicholas Samonas
To truly supercharge growth, should Aledade take a step back and focus on product development? View Details
- 2017
- Article
The Impact of Training Informal Healthcare Providers in India: A Randomized Controlled Trial
By: Jishnu Das, Abhijit Chowdhury, Reshmaan Hussam and Abhijit Banerjee
Health care providers without formal medical qualifications provide more than 70% of all primary care in rural India. Training these informal providers may be one way to improve the quality of care where few alternatives exist. We report on a randomized controlled... View Details
Keywords: Health Care; India; Business Training; RCT; Health Care and Treatment; Training; Performance Evaluation; Performance Improvement; India
Das, Jishnu, Abhijit Chowdhury, Reshmaan Hussam, and Abhijit Banerjee. "The Impact of Training Informal Healthcare Providers in India: A Randomized Controlled Trial." Science 354, no. 6308 (October 7, 2016): 80.
- May 2016
- Article
Transformation of Health Care—Perspectives of Opinion Leaders
By: Joanne Disch, Thomas W. Feeley, Diana J. Mason, Richard L. Schilsky, Ellen L. Stovall and Shelley Fuld Nasso
"What Health System Transformations Do You Believe Are Necessary for the Future of Health Care?" We need to transform to a true value-based health care delivery system. That means organizing care around medical conditions, not simply around hospitals and doctors. We... View Details
- March 2010 (Revised October 2011)
- Case
Highland District County Hospital: Gastroenterology Care in Sweden
By: Michael E. Porter, Jennifer F Baron and Martin Rejler
Sweden's Highland District County Hospital, similar to a community hospital in the US, undertook a major restructuring to integrate care delivery for medical conditions served by the Department of Medicine. Each subspecialty within the Department would form a single,... View Details
Porter, Michael E., Jennifer F Baron, and Martin Rejler. "Highland District County Hospital: Gastroenterology Care in Sweden." Harvard Business School Case 710-469, March 2010. (Revised October 2011.)
- September 2013
- Supplement
The Abraaj Group and the Acibadem Healthcare Investment (B)
By: Paul A. Gompers, Bora Uluduz and Firdevs Abacioglu
This case provides an update on the ultimate outcome of the transaction presented in The Abraaj Group and the Acibadem Healthcare Investment (A). View Details
Gompers, Paul A., Bora Uluduz, and Firdevs Abacioglu. "The Abraaj Group and the Acibadem Healthcare Investment (B)." Harvard Business School Supplement 214-022, September 2013.
- 12 Nov 2014
- News
Bridging Health Care’s Innovation-Education Gap
- Article
Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study
By: Maryaline Catillon
Keywords: Biomedical Research; R＆D; Innovation; Technology; Drug Trials; RCT; Health; Healthcare; Health Care And Treatment; Health Care Policy; Innovation and Invention; Innovation Strategy; Research and Development; Technological Innovation; Health Industry; Health Industry
Catillon, Maryaline. "Trends and Predictors of Biomedical Research Quality, 1990–2015: A Meta-Research Study." BMJ Open 9, no. 9 (September 2019).
- 06 Jan 2015
- News